Clinical trial
A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients…
NCT00206245 · AstraZeneca, Industry · Completed
Key facts
| NCT number | NCT00206245 |
|---|---|
| Title | A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients With Erosive Esophagitis. |
| Official title | A Randomised, Double-blind, Multicentre Dose-finding Phase IIb Study for up to 8 Weeks' Treatment With AZD0865 25, 50, 75 mg and Esomeprazole 40 mg, Given Orally Once Daily for the Healing of Erosive Esophagitis in Adult Subjects With GERD With Erosive Esophagitis According to the LA Classification… |
| Lead sponsor | AstraZeneca, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | GERD With Erosive Esophagitis |
| Intervention type | Drug |
| Interventions | AZD0865 |
| Enrollment | 1,400 |
| Start date | May 1, 2004 |
| Completion | Mar 1, 2005 |
| First posted | Sep 21, 2005 |
| Last update posted | Jan 4, 2013 |
| Countries | Canada, Denmark, Finland, France, Germany, Italy, Norway, Sweden, United Kingdom, United States |
At a glance
- 100–999 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: